Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2023 年第 4 季持倉
持倉截至 2023/12/31，2024/2/14 申報。只含多頭部位，變化是跟 2023 年第 3 季比股數。
- 持股檔數
- 57
- 較 2023 年第 3 季 −5
- 總值
- $28.5 億
- 較 2023 年第 3 季 +$2.76 億 (+10.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| INSMINSMED Inc | COM PAR $.01 | 5,350,000 | $1.66 億 | 5.8% | −650,000−10.8% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 4,063,676 | $1.48 億 | 5.2% | +517,241+14.6% | 加碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 2,000,000 | $1.43 億 | 5.0% | −600,000−23.1% | 減碼 | 歷史 |
| GHGuardant Health, Inc. | COM | 5,000,000 | $1.35 億 | 4.7% | +950,000+23.5% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 300,000 | $1.14 億 | 4.0% | +300,000 | 新進 | 歷史 |
| ALKSAlkermes plc. | SHS | 4,000,000 | $1.11 億 | 3.9% | +200,000+5.3% | 加碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 5,750,000 | $1.04 億 | 3.6% | +250,000+4.5% | 加碼 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 7,093,214 | $9,916 萬 | 3.5% | +336,258+5.0% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 1,000,000 | $7,959 萬 | 2.8% | −140,745−12.3% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 3,631,728 | $7,910 萬 | 2.8% | +668,461+22.6% | 加碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 11,869,297 | $7,644 萬 | 2.7% | −3,130,703−20.9% | 減碼 | 歷史 |
| PACBPacific Biosciences of California, Inc. | COM | 7,000,000 | $6,867 萬 | 2.4% | +1,000,000+16.7% | 加碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 2,250,000 | $6,860 萬 | 2.4% | +250,000+12.5% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 7,370,000 | $6,626 萬 | 2.3% | 00.0% | 不變 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 2,323,456 | $6,492 萬 | 2.3% | −90,917−3.8% | 減碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 3,187,415 | $6,337 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 1,249,068 | $6,319 萬 | 2.2% | −1,585,001−55.9% | 減碼 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 3,490,506 | $6,311 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| GERNGeron Corp | COM | 29,583,449 | $6,242 萬 | 2.2% | +3,883,449+15.1% | 加碼 | 歷史 |
| EDITEditas Medicine, Inc. | COM | 5,473,086 | $5,544 萬 | 1.9% | −1,628,849−22.9% | 減碼 | 歷史 |
| AMAMAmbrx Biopharma, Inc. | COM | 3,710,412 | $5,284 萬 | 1.9% | +3,710,412 | 新進 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 500,000 | $4,822 萬 | 1.7% | +500,000 | 新進 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 1,815,854 | $4,754 萬 | 1.7% | +1,815,854 | 新進 | 歷史 |
| HLVXHilleVax, Inc. | COM | 2,900,000 | $4,655 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 2,284,372 | $4,628 萬 | 1.6% | −493,735−17.8% | 減碼 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 4,297,438 | $4,598 萬 | 1.6% | +4,297,438 | 新進 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 1,793,966 | $4,458 萬 | 1.6% | +293,966+19.6% | 加碼 | 歷史 |
| ANABAnaptysbio, Inc | COM | 2,036,990 | $4,363 萬 | 1.5% | +691,177+51.4% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 1,000,000 | $4,213 萬 | 1.5% | −1,797,955−64.3% | 減碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,952,760 | $4,202 萬 | 1.5% | +1,952,760 | 新進 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 9,230,769 | $4,117 萬 | 1.4% | +9,230,769 | 新進 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 725,145 | $4,025 萬 | 1.4% | +725,145 | 新進 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 6,100,000 | $3,959 萬 | 1.4% | +100,000+1.7% | 加碼 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,951,580 | $3,390 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| ORTXOrchard Therapeutics plc | SPON ADS NEW | 2,041,670 | $3,359 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| NUVLNuvalent, Inc. | COM | 450,000 | $3,312 萬 | 1.2% | +450,000 | 新進 | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 600,000 | $3,308 萬 | 1.2% | +200,000+50.0% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 2,997,830 | $3,094 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 2,537,176 | $2,776 萬 | 1.0% | −212,824−7.7% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 1,930,894 | $2,709 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,000,000 | $2,660 萬 | 0.9% | −403,672−16.8% | 減碼 | 歷史 |
| AGENAgenus Inc | COM NEW | 31,697,539 | $2,624 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 288,949 | $2,412 萬 | 0.8% | +288,949 | 新進 | 歷史 |
| AGIOAgios Pharmaceuticals, Inc. | COM | 1,062,881 | $2,367 萬 | 0.8% | +640,634+151.7% | 加碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 2,992,731 | $2,185 萬 | 0.8% | −75,000−2.4% | 減碼 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 1,011,829 | $1,902 萬 | 0.7% | +657,974+185.9% | 加碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 300,000 | $1,223 萬 | 0.4% | −1,615,000−84.3% | 減碼 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,523,000 | $1,178 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| NKTRNektar Therapeutics | COM | 18,400,000 | $1,040 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 2,044,507 | $846.4 萬 | 0.3% | −793,311−28.0% | 減碼 | 歷史 |
| ALLKAllakos Inc. | COM | 2,510,736 | $685.4 萬 | 0.2% | +2,510,736 | 新進 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 828,485 | $645.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 275,201 | $631.0 萬 | 0.2% | +275,201 | 新進 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 48,280 | $593.8 萬 | 0.2% | −1,089,765−95.8% | 減碼 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 1,594,931 | $539.1 萬 | 0.2% | −172,200−9.7% | 減碼 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM | 6,102,770 | $405.2 萬 | 0.1% | +6,102,770 | 新進 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 499,400 | $289.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2023 年第 3 季之後清倉（18 檔）
2023 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 3 季股數 | 2023 年第 3 季市值 | 2023 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| NVCRNovoCure Ltd | ORD SHS | 2,500,000 | $4,038 萬 | 1.6% | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 300,000 | $3,375 萬 | 1.3% | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 1,015,641 | $2,443 萬 | 0.9% | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 1,259,335 | $2,306 萬 | 0.9% | 歷史 |
| BNTXBioNTech SE | SPONSORED ADS | 200,000 | $2,173 萬 | 0.8% | 歷史 |
| MRNAModerna, Inc. | Stock | 200,000 | $2,066 萬 | 0.8% | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 2,781,565 | $1,855 萬 | 0.7% | 歷史 |
| MORFMorphic Holding, Inc. | COM | 470,647 | $1,078 萬 | 0.4% | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 2,513,044 | $1,043 萬 | 0.4% | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 7,720,688 | $1,035 萬 | 0.4% | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 1,037,873 | $774.3 萬 | 0.3% | 歷史 |
| TXG10x Genomics, Inc. | CL A COM | 182,691 | $753.6 萬 | 0.3% | 歷史 |
| NVAXNovavax Inc | COM NEW | 1,000,000 | $724.0 萬 | 0.3% | 歷史 |
| SLRNACELYRIN, Inc. | COM | 551,289 | $560.7 萬 | 0.2% | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 328,424 | $243.0 萬 | 0.1% | 歷史 |
| HRTXHeron Therapeutics, Inc. | COM | 2,086,704 | $214.9 萬 | 0.1% | 歷史 |
| ETNB89bio, Inc. | COM | 91,078 | $140.6 萬 | 0.1% | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 543,008 | $108.6 萬 | <0.1% | 歷史 |